COLLEEN DIFERDINANDO: Open Payments
NPI 1558946533 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 15 payments from 12 companies in 2025. Trend: 2023 $73 · 2024 $178 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $62 |
| Organon LLC | 3 | $46 |
| Edwards Lifesciences Corporation | 1 | $32 |
| Medtronic, Inc. | 1 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $28 |
| Dexcom, Inc. | 1 | $25 |
| Seqirus USA Inc | 1 | $23 |
| Phadia US Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: UBRELVY, NEXPLANON, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), SYMPLICITY G3, OPSUMIT, Dexcom G6 Transmitter, Fluad, ImmunoCAP.
Industry payments across CO — which companies pay providers there.
